BeiGene, Ltd.
ONC
$230.98
$2.841.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.44% | -25.35% | 52.06% | 24.98% | -267.78% |
| Total Depreciation and Amortization | 456.15% | -297.44% | -1.48% | -71.28% | 304.68% |
| Total Amortization of Deferred Charges | 304.51% | -296.47% | -0.51% | -68.36% | 326.44% |
| Total Other Non-Cash Items | 213.08% | -33.27% | 55.96% | -67.27% | 159.91% |
| Change in Net Operating Assets | -159.68% | 332.21% | 27.00% | 58.07% | -211.66% |
| Cash from Operations | -19.61% | 245.24% | 69.02% | 22.02% | -434.63% |
| Capital Expenditure | 42.14% | -37.95% | 29.78% | -25.13% | 29.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -200.26% | 14,808.01% | 97.97% | 75.00% | -182.77% |
| Cash from Investing | -3,415.17% | 106.72% | 47.09% | 37.95% | -529.98% |
| Total Debt Issued | 807.07% | -66.84% | 20.72% | -69.81% | 8,240.55% |
| Total Debt Repaid | -785.74% | 62.43% | -4,592.12% | 97.69% | 78.21% |
| Issuance of Common Stock | -97.60% | 2,780.82% | -62.38% | 1,187.07% | -99.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 113.77% | -5,472.58% | -- | -- | 114.10% |
| Cash from Financing | 300.68% | -165.06% | -85.82% | -57.42% | 438.20% |
| Foreign Exchange rate Adjustments | -292.11% | 540.91% | 73.70% | -57.16% | -124.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.93% | 183.02% | 49.94% | -3.15% | -359.33% |